Author

G. Esteso

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Assay:flow cytometry· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

M. Vales-Gomez· 3 shared H. T. Reyburn· 2 shared L. Martinez-Pineiro· 2 shared A. Dopazo· 1 shared A. Garcia-Jimenez· 1 shared A. Leibar· 1 shared A. Linares· 1 shared C. Blish· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Vales-Gomez

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Long-term cytotoxic NK cells with broad anti-tumour capacity proliferate selectively, without exhaustion, after BCG priming and extremely low doses of cytokines

M.-J. Felgueres, G. Esteso, A. Garcia-Jimenez, A. Dopazo, L. Martinez-Pineiro, H. T. Reyburn, M. Vales-Gomez

This paper describes a method to generate long-lived, cytotoxic NK cells with broad anti-tumour activity using BCG priming and low-dose cytokines, without cell sorting or exhaustion.

bioRxiv · Jun 7, 2023 · PreprintImmunology

CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients

E. Castellano, C. Samba, G. Esteso, L. J. Simpson, E. Vendrame, E. M. Garcia-Cuesta, S. Lopez-Cobo, M. Alvarez-Maestro, A. Linares, A. Leibar, T. Ranganath, H. T. Reyburn, L. Martinez-Pineiro, C. Blish, M. Vales-Gomez

The paper uses CyTOF to identify a novel immune cell population in urine of BCG-treated bladder cancer patients, linking it to inflammatory response and potential treatment risk.

bioRxiv · Jun 12, 2020Immunology

Natural killer activation for bladder cancer elimination can be achieved in vitro by heat-killed BCG

G. Esteso, N. Aguilo, E. Julian, O. Ashiru, M. M. Ho, C. Martin, M. Vales-Gomez

The paper shows that heat-killed BCG substrains activate NK cells to eliminate bladder cancer cells in vitro, with Tice, Connaught, and Moreau strains being most effective.

bioRxiv · Jun 4, 2020Immunology